Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT00981123

NIS-NHR-SER-2009/1

Details and patient eligibility

About

Observational, non-comparative, epidemiological study to collect and analyse real life data on schizophrenic patients receiving quetiapine according to the standard medical practice in Croatia. The main objectives are to assess after 6 months of quetiapine therapy severity of illness and global improvement in patients using Clinical Global Impression (CGI) scale.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diagnosis of schizophrenia
• Patients who are already treated with quetiapine for at least 12 weeks (outpatients or hospitalised patients)
• Patients capable of signing ICF

Exclusion criteria

• Patients with hypersensitivity to active substance or any of the excipients of this product
• Patients with contraindication for quetiapine therapy according to the approved SmPC

Trial design

500 participants in 1 patient group

1